Life Science & Medical Technology

Fujifilm Holdings has started to develop a reagent to use in testing patients for the novel coronavirus.

A study of several dozen elderly people suggests that eating Camembert daily may help keep dementia at bay, but not Mozzarella cheese.

With COVID-19 spreading from China to other countries, pharmaceutical, chemical and other companies are rushing to develop quick test kits that promise to facilitate quarantine procedures.

Doctors in Thailand and Japan have used HIV medications to treat patients infected with the novel coronavirus with apparent success. But why did they think to test drugs made to combat one pathogen on a seemingly completely different disease?

A Keio University research team has been given the green light to transplant heart muscle cells derived from iPS cells into patients who have experienced severe heart failure

Takara Bio is preparing to produce 50 times more of a coronavirus testing reagent at its plant in Dalian in response to an urgent request from the Chinese city, where the Japanese drugmaker's main factory is located.

An extremely thin sensor worn around the finger or arm can measure pulses and scan fingerprints and vein patterns, thereby preventing identification mix-ups among medical patients and nursing care residents, the device’s developers said.

A patient who received the world’s first transplant of cardiac muscle cells using artificially derived stem cells known as iPS cells this month is in stable condition, an Osaka University team said Jan. 27.

Daiichi Sankyo, a Japanese drugmaker that has not had a blockbuster product for nearly a decade, is surging in market value, joining the 5 trillion yen ($46 billion) club that also includes such marquee names as Nintendo and Honda Motor.

Aspirin, aside from acting as a mild pain reliever, could help control the development of dementia among women with diabetes, researchers say.